Openbookopenbook
Equity
Twist Bioscience Corp(TWST)
USD --+0.00%
Reward49Moderate
Risk55Medium-High
📊75%Data
Thin -20% profit margin · Revenue growing 17% YoY
TWST
+0.0 · +0.00%
USD · NASDAQ
Twist Bioscience Corp | Healthcare
Profitless Growth
Market Cap:2.88Bn
ℹ️
Reward Rating
49
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
55
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on TWST to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $49.89.

What is Twist Bioscience Corp?

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.

TWST · Verdict

Moderate reward · elevated risk

TWST's standout is balance sheet; volatility and profitability weigh on the picture.

Based on 88% data coverage

TWST · Verdict

What’s working & what to watch

Strengths 1

  • Balance sheet86/100

    Current ratio 3.64

Watchouts 3

  • Volatility5/100

    Weak vs peers

  • Profitability24/100

    -21% net margin · -17% ROE

  • Cash flow25/100

    -20% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Twist Bioscience Corp?

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 2.88B.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (49)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.88B
P/E RatioN/A
Dividend YieldN/A
52 Week High57.88
52 Week Low23.3
Last AnnualSeptember
IPO Date10/31/2018
IncorporatedUSA
Shares Outstanding61M
No. of Employees979
IndustryDiagnostics & Research
ExchangeNASDAQ
Beta2.268
CurrencyUSD
Websitewww.twistbioscience.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.